AMRX - Amneal Pharmaceuticals, Inc.
13.24
-0.020 -0.151%
Share volume: 1,550,712
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$13.26
-0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 08-09-2024 | 11-12-2024 | 02-28-2025 | 05-07-2025 | 08-07-2025 | 11-06-2025 | 02-27-2026 | |
| Assets | |||||||||
| Total Assets | 3.456 B | 3.510 B | 3.461 B | 3.501 B | 3.365 B | 3.423 B | 3.600 B | 3.678 B | |
| Current Assets | 1.380 B | 1.485 B | 1.513 B | 1.588 B | 1.510 B | 1.585 B | 1.838 B | 1.911 B | |
| Inventories | 570.653 M | 575.624 M | 596.359 M | 612.454 M | 601.433 M | 608.973 M | 614.500 M | 606.302 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 46.520 M | 43.769 M | 74.006 M | 110.552 M | 59.187 M | 71.544 M | 201.249 M | 282.029 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 439.815 M | 425.380 M | 431.020 M | 424.908 M | 427.231 M | 440.327 M | 434.991 M | 442.950 M | |
| Other Assets | 1.637 B | 1.599 B | 1.517 B | 1.489 B | 1.428 B | 1.398 B | 1.326 B | 1.324 B | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 3.456 B | 3.510 B | 3.461 B | 3.501 B | 3.365 B | 3.423 B | 3.600 B | 3.678 B | |
| Total liabilities | 3.473 B | 3.514 B | 3.495 B | 3.546 B | 3.425 B | 3.470 B | 3.642 B | 3.672 B | |
| Total current liabilities | 834.388 M | 1.114 B | 1.095 B | 1.130 B | 1.076 B | 1.107 B | 862.106 M | 881.633 M | |
| Accounts Payable | 575.593 M | 631.967 M | 684.007 M | 757.761 M | 694.777 M | 730.213 M | 800.037 M | 816.801 M | |
| Other liabilities | 175.430 M | 136.579 M | 144.363 M | 112.054 M | 121.856 M | 141.505 M | 83.294 M | 98.823 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 2.378 B | 2.178 B | 2.170 B | 2.162 B | 2.154 B | 2.146 B | 2.567 B | 2.565 B | |
| Other liabilities | 175.430 M | 136.579 M | 144.363 M | 112.054 M | 121.856 M | 141.505 M | 83.294 M | 98.823 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -63.724 M | -57.465 M | -93.432 M | -109.267 M | -131.667 M | -112.118 M | -109.458 M | -70.794 M | |
| Common stock | 541.806 M | 548.796 M | 556.331 M | 563.305 M | 548.940 M | 557.763 M | 566.506 M | 574.940 M | |
| Retained earnings | -581.819 M | -575.825 M | -575.981 M | -607.062 M | -594.867 M | -572.450 M | -570.081 M | -535.005 M |